Semin Liver Dis 2020; 40(02): 163-170
DOI: 10.1055/s-0039-3400259
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Emerging Role of Palliative Care in Patients with Advanced Liver Disease

Roberta I. Jordan
1   Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom
,
Puneeta Tandon
2   Division of Gastroenterology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Alberta, Canada
› Author Affiliations
Funding This research is supported by the National Institute for Health Research (NIHR) infrastructure at Leeds. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.
Further Information

Publication History

Publication Date:
15 November 2019 (online)

Abstract

Advanced liver disease is increasing in mortality and morbidity worldwide, as a result of growing alcohol consumption, obesity, and viral hepatitis infection. Alongside efforts to reduce these factors, it is clear that we must identify the considerable palliative care needs of these patients in order to improve quality of life and reduce symptom burden. Our review focuses on the current state of palliative and end-of-life care for patients with advanced liver disease, the significant associated symptom burden in this disease group, identified level of involvement and potential benefits of specialist palliative care, as well as possible barriers to accessing this care. We demonstrate that although palliative care involvement varies considerably worldwide, there is much opportunity for improvement. Further research is needed to determine new interventions and models of care that may improve access for patients with liver disease, including an expansion of providers comfortable with generalist palliative care.

 
  • References

  • 1 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
  • 2 Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med 2014; 17 (11) 1271-1277
  • 3 Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 2018; 362: k2817
  • 4 Williams R, Aspinall R, Bellis M. , et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014; 384 (9958): 1953-1997
  • 5 Murray CJL, Vos T, Lozano R. , et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2197-2223
  • 6 National Institute on Alcohol Abuse and Alcoholism. Yoon Y-H, Chen CM. Surveillance Report# 105: Liver cirrhosis mortality in the United States: National, state, and regional trends, 2000–2013. Bethesda, MD: National Institutes of Health; October. 2016. Available at: https://pubs.niaaa.nih.gov/publications/surveillance105/Cirr13.pdf . Accessed November 4, 2019
  • 7 National End of Life Care Intelligence Network. Effiong K, Osinowo A, Pring A, Verne J. Deaths from liver disease: implications for end of life care in England. Bristol, UK: National End of Life Care Intelligence Network; March. 2012. Available at: https://webarchive.nationalarchives.gov.uk/20190501131924/http://www.endoflifecare-intelligence.org.uk/resources/publications/deaths_from_liver_disease . Accessed November 4, 2019
  • 8 Wong MCS, Huang J. The growing burden of liver cirrhosis: implications for preventive measures. Hepatol Int 2018; 12 (03) 201-203
  • 9 Peng J-K, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med 2019; 33 (01) 24-36
  • 10 Ufere NN, Donlan J, Waldman L. , et al. Physicians' perspectives on palliative care for patients with end-stage liver disease: a national survey study. Liver Transpl 2019; 25 (06) 859-869
  • 11 World Health Organisation. Cancer: WHO Definition of Palliative Care. WHO; 2019 . Available at: https://www.who.int/cancer/palliative/definition/en/ . Accessed July 11, 2019
  • 12 Carvalho JR, Vasconcelos M, Marques da Costa P. , et al. Identifying palliative care needs in a Portuguese liver unit. Liver Int 2018; 38 (11) 1982-1987
  • 13 Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X. Identification of people with chronic advanced diseases and need of palliative care in sociosanitary services: elaboration of the NECPAL CCOMS-ICO© tool [in Spanish]. Med Clin (Barc) 2013; 140 (06) 241-245
  • 14 López-Navas A, Rios A, Riquelme A. , et al. Importance of introduction of a psychological care unit in a liver transplantation unit. Transplant Proc 2010; 42 (01) 302-305
  • 15 Hudson B, Hunt V, Waylen A, McCune CA, Verne J, Forbes K. The incompatibility of healthcare services and end-of-life needs in advanced liver disease: a qualitative interview study of patients and bereaved carers. Palliat Med 2018; 32 (05) 908-918
  • 16 Kimbell B, Boyd K, Kendall M, Iredale J, Murray SA. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open 2015; 5 (11) e009241
  • 17 Day R, Hollywood C, Durrant D, Perkins P. Patient experience of non-malignant ascites and its treatment: a qualitative study. Int J Palliat Nurs 2015; 21 (08) 372-379
  • 18 Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol 2014; 12 (04) 692-698
  • 19 Brown CL, Hammill BG, Qualls LG, Curtis LH, Muir AJ. Significant morbidity and mortality among hospitalized end-stage liver disease patients in Medicare. J Pain Symptom Manage 2016; 52 (03) 412-419.e1
  • 20 Najafian N, Sack JS, DeLisle AM, Jakab S. Advance care planning for patients with cirrhosis in a structured inpatient/outpatient hepatology program [abstract]. J Palliat Med 2019; 22 (11) 1445-1448
  • 21 Hudson B, Round J, Georgeson B. , et al. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. Lancet Gastroenterol Hepatol 2018; 3 (02) 95-103
  • 22 Low J, Davis S, Vickerstaff V. , et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open 2017; 7 (08) e016887
  • 23 Department of Health. First National VOICES Survey of Bereaved People: Key Findings Report. London, UK: Department of Health; July 2012
  • 24 Antaki F, Lukowski A. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice. J Clin Gastroenterol 2007; 41 (04) 412-415
  • 25 Medici V, Rossaro L, Wegelin JA. , et al. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transpl 2008; 14 (08) 1100-1106
  • 26 Chang H-T, Lin M-H, Chen C-K, Chou P, Chen T-J, Hwang S-J. Trends of Do-Not-Resuscitate consent and hospice care utilization among noncancer decedents in a tertiary hospital in Taiwan between 2010 and 2014: a hospital-based observational study. Medicine (Baltimore) 2016; 95 (46) e5394
  • 27 Kathpalia P, Smith A, Lai JC. Underutilization of palliative care services in the liver transplant population. World J Transplant 2016; 6 (03) 594-598
  • 28 Perri G-A, Bunn S, Oh YJ. , et al. Attributes and outcomes of end stage liver disease as compared with other noncancer patients admitted to a geriatric palliative care unit. Ann Palliat Med 2016; 5 (02) 76-82
  • 29 Rosenwax L, Spilsbury K, McNamara BA, Semmens JB. A retrospective population based cohort study of access to specialist palliative care in the last year of life: who is still missing out a decade on?. BMC Palliat Care 2016; 15: 46
  • 30 Fukui N, Golabi P, Otgonsuren M, Mishra A, Venkatesan C, Younossi ZM. Demographics, resource utilization, and outcomes of elderly patients with chronic liver disease receiving hospice care in the United States. Am J Gastroenterol 2017; 112 (11) 1700-1708
  • 31 Kelly SG, Campbell TC, Hillman L, Said A, Lucey MR, Agarwal PD. The utilization of palliative care services in patients with cirrhosis who have been denied liver transplantation: a single center retrospective review. Ann Hepatol 2017; 16: 395-401
  • 32 Patel AA, Walling AM, Ricks-Oddie J, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol 2017; 15 (10) 1612-1619.e4
  • 33 Rush B, Walley KR, Celi LA, Rajoriya N, Brahmania M. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology 2017; 66 (05) 1585-1591
  • 34 Spilsbury K, Rosenwax L, Arendts G, Semmens JB. The association of community-based palliative care with reduced emergency department visits in the last year of life varies by patient factors. Ann Emerg Med 2017; 69 (04) 416-425
  • 35 Allsop MJ, Ziegler LE, Mulvey MR, Russell S, Taylor R, Bennett MI. Duration and determinants of hospice-based specialist palliative care: a national retrospective cohort study. Palliat Med 2018; 32 (08) 1322-1333
  • 36 Oud L. Patterns of palliative care utilization among patients with end stage liver disease during end-of-life hospitalizations: a population-level analysis. J Crit Care 2018; 48: 290-295
  • 37 Rush B, Fruhstofer C, Walley KR, Celi LA, Brahmania M. Palliative medicine and hospital readmissions in end-stage liver disease. BMJ Support Palliat Care 2019; DOI: 10.1136/bmjspcare-2018-001635. [epub ahead of print]
  • 38 Knaul FM, Farmer PE, Krakauer EL. , et al; Lancet Commission on Palliative Care and Pain Relief Study Group. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet 2018; 391 (10128): 1391-1454
  • 39 Gaertner J, Siemens W, Meerpohl JJ. , et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ 2017; 357: j2925
  • 40 Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 2013; (06) CD007760 . Doi: 10.1002/14651858.CD007760.pub2
  • 41 Kavalieratos D, Corbelli J, Zhang D. , et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 2016; 316 (20) 2104-2114
  • 42 Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage 2015; 50 (06) 882-6.e2
  • 43 Spilsbury K, Rosenwax L. Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life. BMC Palliat Care 2017; 16 (01) 68
  • 44 Kimbell B, Murray SA, Byrne H. , et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med 2018; 32 (05) 919-929
  • 45 Low JTS, Rohde G, Pittordou K. , et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol 2018; 69 (06) 1260-1273
  • 46 Low J, Vickerstaff V, Davis S. , et al. Palliative care for cirrhosis: a UK survey of health professionals' perceptions, current practice and future needs. Frontline Gastroenterol 2016; 7 (01) 4-9
  • 47 British Association for the study of the Liver. Clinical Guideline: Symptom Control and End of Life care in Adults with Advanced Liver Disease. Bristol, UK: BASL; 2019
  • 48 Esteban JPG, Rein L, Szabo A, Saeian K, Rhodes M, Marks S. Attitudes of liver and palliative care clinicians toward specialist palliative care consultation for patients with end-stage liver disease. J Palliat Med 2019; 22 (07) 804-813
  • 49 Goddard M, Smith P. Equity of access to health care services: theory and evidence from the UK. Soc Sci Med 2001; 53 (09) 1149-1162
  • 50 Highet G, Crawford D, Murray SA, Boyd K. Development and evaluation of the Supportive and Palliative Care Indicators Tool (SPICT): a mixed-methods study. BMJ Support Palliat Care 2014; 4 (03) 285-290
  • 51 Hudson BE, Ameneshoa K, Gopfert A. , et al. Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention. Frontline Gastroenterol 2017; 8 (01) 45-52
  • 52 British Association for the study of the Liver. Validation Study to Evaluate whether Prognostic Screening Tools Assess Palliative Care Needs in Patients with Advanced Liver Disease. UK: BASL; 2019